Pharma - HealthQuill

Merck & Co’s combination drug, Keytruda, which treats advanced lung cancer, has been approved by the US drug regulator, the Food and Drug Administration.

Merck’s advanced lung cancer drug gets US drug regulator’s nod

Merck & Co’s combination drug, Keytruda, which treats advanced lung cancer, has been approved by the US drug regulator, the Food and Drug.

by HealthQuill
September 19, 2024
0 Comments

Surgery-free cataracts may be possible in the future after researchers at the National Institutes of Health discovered a protein that can reverse and manage the clouding of the eye’s lens or lead to the development of a drug.

Drugs Health Pharma

Protein discovery in animal studies holds hope for surgery-free cataract

Surgery-free cataracts may be possible in the future after researchers at the National Institutes of Health discovered a protein that can reverse and.

by HealthQuill
September 18, 2024
1 Comment

US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.

Drugs Health Pharma

Organon & Co to buy Riovant’s arm Dermavant Sciences for $1.2 billion

US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.

by HealthQuill
September 18, 2024
0 Comments

The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.

Drugs Health Pharma

AstraZeneca’s rare disease drug Fasenra gets US regulator’s nod

The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.

by HealthQuill
September 18, 2024
0 Comments

Antibiotic-resistant infections may kill 39.1 million people in the next 25 years equating to three deaths a minute, a global study finds.

Drugs Health Pharma

Antimicrobial resistance may kill 39.1 million people by 2050: GRAM

Antibiotic-resistant infections may kill 39.1 million people in the next 25 years equating to three deaths a minute, a global study finds.

by HealthQuill
September 18, 2024
0 Comments

Daiichi Sankyo and Merck & Co., Inc. will initiate talks with global regulatory agencies after an end-stage trial of its drug for a form of lung cancer improved patients’ chances of extending survival without the disease progressing.

Drugs Health Pharma

Daiichi Sankyo-Merck’s trial lung cancer drug meets primary goal

Daiichi Sankyo and Merck & Co., Inc. will initiate talks with global regulatory agencies after an end-stage trial of its drug for a.

by HealthQuill
September 17, 2024
0 Comments

The aid got diverted to fighting inflation, debt, and new wars. “Unfortunately, aid isn’t keeping pace with these needs, particularly in the places that need it the most.”

Climate Health Pharma

40 million children will experience stunted growth in next 26 years: Gates

Billionaire Bill Gates, who describes malnutrition as the “world’s worst child health crisis,” said in the next 25 years, about 40 million children will be.